XBIO – xenetic biosciences, inc. (US:NASDAQ)
Stock Stats
News
Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis [Yahoo! Finance]
Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis
Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results
Xenetic Biosciences, Inc. Presents Positive Data Demonstrating DNase I Significantly Improves Efficacy of Anti-CTLA-4 Immune Checkpoint Blockade in Preclinical Colorectal Carcinoma Models
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
Form 8-K Xenetic Biosciences, For: Nov 13
Form 10-Q Xenetic Biosciences, For: Sep 30
Form 8-K Xenetic Biosciences, For: Nov 01
Form EFFECT Xenetic Biosciences,
Form 8-K Xenetic Biosciences, For: Oct 29
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.